The pharmaceutical goods market size value per capita in Finland exhibited a notable decline, falling from 44.01 in 2012 to 24.67 in 2022. This represents a clear downward trend marked by a consistent year-on-year decrease. In the last two years, the market saw a 3.9% drop in 2021 followed by a more pronounced 13.9% decline in 2022.
Analyzing the data over the last five years, from 2018 to 2022, the Compound Annual Growth Rate (CAGR) reveals an average annual reduction of about 4.1%. The most significant decreases occurred in 2018 and 2019, with declines of 12.0% and 6.7%, respectively. By 2023, the market size value per capita stood at an estimated 21.9, indicating a continuing downward trend.
Future trends to watch for include potential stabilization or growth driven by advancements in pharmaceutical technology, increased healthcare accessibility, and government policies promoting healthcare investments. Monitoring emerging therapies and demographic changes will be key to anticipating market shifts in the pharmaceutical sector.
How does Finland rank in Pharmaceutical Goods Market Size Value Per Capita?
| # | 41 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Norway | 44.82 | 2023 | View data | ||
| 2 | 2 Australia | 41.26 | 2023 | View data | ||
| 3 | 3 Germany | 40.08 | 2023 | View data | ||
| 4 | 4 Switzerland | 38.82 | 2023 | View data | ||
| 5 | 5 Austria | 38.7 | 2023 | View data | ||
| 17 | 17 Denmark | 22.93 | 2023 | View data | ||
| 18 | 18 Slovakia | 21.56 | 2023 | View data | ||
| 19 | 19 Finland | 20.59 | 2023 | |||
| 20 | 20 South Korea | 20.12 | 2023 | View data | ||
| 21 | 21 Greece | 19.86 | 2023 | View data | ||
